| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 12, 2026 | MARIO & COURTNEY LOPEZ TAKE OVER AND EXECUTIVE PRODUCE 'THE BALANCING ACT®' AIRING ON LIFETIME® | The Balancing Act with Mario & Courtney Lopez Photo
MAJOR SHIFT FOR THE LONG-RUNNING SERIES - Celebrity Power Couple to Lead Iconic Morning Show into Its 25th Anniversary Season with a Fresh, Family-Driven Format POMPANO BEACH, FL, UNIT... |
| Jan 22, 2026 | Dr. Raymond Douglas to Appear on The Balancing Act® to Spotlight Thyroid Eye Disease Awareness | Beverly Hills oculoplastic surgeon and Tepezza pioneer joins fellow experts and a patient to shed light on an often-misunderstood autoimmune eye condition. LOS ANGELES, CA, UNITED STATES, January 22, 2026 /EINPresswire.com/ -- Renowned phys... |
| May 9, 2025 | Award-Winning Morning Show 'The Balancing Act' Presents Mission Matrimony from Mexico City | Mission Matrimony - The Balancing Act
Jared and Sydney Bowman received a 10-year vow renewal celebration at Live Aqua Urban Resort, courtesy of The Balancing Act, airing May 12th & 20th on Lifetime.
This episode is about choosing love a... |
| Aug 29, 2024 | 1891 Financial Life to Be Featured on The Balancing Act® on Lifetime TV® | 1891 Financial Life CEO Lisa Bickus tells the story about the impact of 1891 Financial Life’ life insurance within our communities for 133 years.
Life insurance is about creating financial stability and generational wealth at the same time ... |
| Apr 11, 2024 | Designing Spaces Teams Up with The UPS Foundation and Be Strong to Support Wellspring Living | Designing Spaces
Wellspring is an Atlanta based non-profit building solutions for human trafficking survivors through therapy, housing, and educational resources.
We commend Wellspring Living, UPS Foundation, Be Strong, and our other partne... |
| Mar 4, 2024 | Nicole Oropesa Named President of BrandStar Entertainment | Nicole Oropesa, President BrandStar Entertainment
Acclaimed industry veteran will oversee all branded entertainment show properties.
Nicole’s dedication, expertise, and journey with BrandStar exemplifies her exceptional leadership. Her visi... |
| Mar 4, 2024 | Navigating Your Rare Disease Guide Released on Rare Disease Day to Raise Awareness and Empower Individuals | Navigating Your Rare Disease Guide
This beginner's guide serves as a valuable resource for newly diagnosed rare disease patients, equipping them with the support and tools needed to navigate their unique healthcare journeys”
— Molly Mager, ... |
| Apr 25, 2023 | Renowned Leadership Expert Dr. Yasmin Davidds to Be Featured on National Television; Provides Insight In Transformative Power of her Virtual Leadership Programs for Women | Dr. Yasmin Davidds, CEO of Dr. Yasmin Davidds Leadership Institute and Founder of the Multicultural Women Executive Leadership Foundation, will be interviewed on Lifetime Channel’s The Balancing Act. “My hope is that professional women and ... |
| Jul 7, 2022 | Pharmacists 'ready to get to work' after new FDA authorization allows them to prescribe Pfizer's Covid-19 antiviral | Bausch Health is in trouble again with the FDA for marketing its Duobrii plaque psoriasis cream. This time the OPDP’s untitled letter charges multiple issues with a “misleading” video and problematic efficacy claims on Duobrii’s webpage. Th... |
| Jun 13, 2022 | DSF Highlights New Episode of Lifetime® TV’s “Behind the Mystery” Segment of “The Balancing Act®” on Dravet syndrome | Dravet Foundation Logo
The extended 30-minute “special edition” live segment follows the diagnosis and treatment journey of a Dravet patient and family. CHERRY HILL, NJ, USA, June 13, 2022 /EINPresswire.com/ -- Today, the Dravet Syndrome Fo... |
| Jun 10, 2022 | Maximizing Branded Entertainment Opportunities | Nicole Oropesa, EVP Marketing and Business Development, BrandStar Entertainment
Maximizing Branded Entertainment Opportunities, By Nicole Oropesa, VP of Programing, BrandStar Entertainment
The value of Branded Entertainment cannot be overst... |
| Apr 13, 2022 | 'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear | To treat corneal endothelial dysfunction, a condition that causes the outer layer of the eye to swell and go hazy, doctors generally rely on cell transplants.
A highly-trained surgeon rolls out an incredibly thin scroll of cells — around th... |
| Apr 13, 2022 | How McKinsey used its FDA connections to help opioid manufacturers: New congressional report | Though last September’s clinical hold on Protagonist Therapeutics was lifted after only a few weeks, the biotech quietly disclosed Wednesday that another FDA concern emerged from the pause.
US regulators intend to revoke the breakthrough th... |
| Apr 13, 2022 | 'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear | Prescription drug names often spark speculation, debates and sometimes derision, but they also stir curiosity.
That’s maybe never been more evident than during the Covid-19 pandemic, when vaccine names were dissected everywhere from Zoom wa... |
| Apr 13, 2022 | 'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear | While heading up the hematology unit at Roche/Genentech, Thomas Fuchs and his team “looked at everything” when trying to address the areas of unmet need in blood-related diseases. Antibodies, small molecules, cell therapi... |
| Apr 13, 2022 | 'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear | As a drug formerly abandoned by Gilead finally looks set to complete its tortuous journey toward FDA approval, GlaxoSmithKline is shelling out $1.9 billion to snap it up.
Sierra Oncology gets the credit for salvaging momelotinib — which Gil... |
| Apr 13, 2022 | 'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear | Three consecutive weekends of celebrity-studded award shows amounted to a flood of pharma advertising on the TV airwaves. First it was Academy Awards in late March, followed by the Grammys last weekend and on Monday night, the Country Music... |
| Apr 13, 2022 | 'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear | The whole premise of the FDA’s accelerated approval pathway rests on the idea that clinical benefit will be established after the approval, via a confirmatory trial, proving the drug was worth authorizing early on.
In many cases, the confir... |
| Apr 13, 2022 | RA, Jeito and Omega back a small Swiss biotech to enter an I/O field paved by Adaptimmune | A licensing deal worth up to $520 million has been fueling little-known Swiss biotech CDR-Life since May 2020, but the five-year-old startup is ready to haul in traditional venture capital financing.
Rafaèle Tordjman
After... |
| Apr 13, 2022 | 'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear | Despite a rising threat of antimicrobial resistance, Big Pharma essentially abandoned the field years ago, unable to see past the high risk and poor financial returns. The UK is looking to change that with a new Netflix-style subscription m... |
| Apr 12, 2022 | Abzena commits chunk of new $65M investment to build out in hot North Carolina scene | A San Diego CDMO has landed a $65 million investment to expand its drug substance and fill-finish manufacturing capacity, and it’s putting some of the money into its newest site on the other side of the country.
Abzena wi... |
| Apr 12, 2022 | Backed by billionaire Mike Platt, Engitix scores another deal with Takeda to go after IBD | Mike Platt
Engitix is on a roll.
The British biotech backed by billionaire hedge fund manager Mike Platt secured an expansion on its earlier Takeda deal, it announced Tuesday morning, winning a new promise of up to $300 mil... |
| Apr 12, 2022 | UPDATED: Myovant and Pfizer’s path to securing a second nod for Myfembree gets hazy — and investors react quickly | Myovant was on tap for a May 6 decision on a supplemental NDA for its three-in-one pill Myfembree, aiming to treat moderate to severe pain associated with endometriosis. With an FDA nod, Myovant would get a $100 million r... |
| Apr 12, 2022 | Stanford spinout racks up more support for its mRNA approach to cellular rejuvenation | As the once-niche field of cellular rejuvenation finds itself under the spotlight on the anti-aging stage — thanks in no small part to Altos Labs’ $3 billion launch, quickly followed by the unveiling of other efforts — an... |
| Dec 3, 2020 | Tune In for The Balancing Act's Behind The Mystery: Rare and Genetic “Special Edition” on Sickle Cell Disease and IgA Nephropathy on Lifetime TV | “To be a patient advocate is to arm yourself with the latest research, knowledge and resources for the community and so far we’ve been able to touch the lives of millions of people through the 100+ disease specific segments we’ve aired so f... |
| Jun 21, 2010 | Shelf-stable seafood resurgence? | The economic downturn has benefited the shelf-stable seafood category, as cost-conscious Americans increasingly look to value-oriented food items like canned and pouched tuna and salmon.
For the 52 weeks ending 12 June, retail volume sales ... |